BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27911269)

  • 1. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
    Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
    Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.
    Zhang H; Fredericks T; Xiong G; Qi Y; Rychahou PG; Li JD; Pihlajaniemi T; Xu W; Xu R
    Breast Cancer Res; 2018 Oct; 20(1):116. PubMed ID: 30285809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
    D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
    Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer.
    Huber MC; Falkenberg N; Hauck SM; Priller M; Braselmann H; Feuchtinger A; Walch A; Schmitt M; Aubele M
    Oncotarget; 2016 Jul; 7(28):44062-44075. PubMed ID: 27286449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
    Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
    Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
    Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ
    J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
    J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pygenic Acid A (PA) Sensitizes Metastatic Breast Cancer Cells to Anoikis and Inhibits Metastasis In Vivo.
    Lim GE; Sung JY; Yu S; Kim Y; Shim J; Kim HJ; Cho ML; Lee JS; Kim YN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
    Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
    Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
    Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
    FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMPK and Akt in triple negative breast cancer lung colonization.
    Johnson J; Chow Z; Lee E; Weiss HL; Evers BM; Rychahou P
    Neoplasia; 2021 Apr; 23(4):429-438. PubMed ID: 33839456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.